Company / Capital Expenditures
Mirum Pharmaceuticals, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$954.0K
FY2025
5-year range
$24.0K / $993.0K
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
#114 of 194
Health Care
What the data says
At $954,000, Mirum Pharmaceuticals, Inc.'s capital expenditures ranks #114 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 8 years, ranging from $0 in FY2018 to $993,000 in FY2024.
Based on SEC 10-K filings.
$954,000 in FY2025 with a 5-year CAGR of +33.5%.
Improved from $109,000 to $954,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +241.3%
- 5-Year CAGR
- +33.5%
- 10-Year CAGR
- -
Sector benchmark
#114 of 194 in Health CareTop 59% of 194This company $954.0K Sector average $117.5M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +33.5%, indicating consistent growth.
- In FY2025, capital expenditures decreased 3.9% year-over-year.
- Ranks #114 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $954.0K | -3.9% |
| FY2024 | $993.0K | +811.0% |
| FY2023 | $109.0K | +354.2% |
| FY2022 | $24.0K | -89.3% |
| FY2021 | $225.0K | +0.0% |
| FY2020 | $225.0K | -19.9% |
| FY2019 | $281.0K | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026